✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Laurus Labs Ltd.

LAURUSLABS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹49,947 Cr.
P/E
73.03

Laurus Labs Ltd.

  • Laurus Labs
  • Neuland Laboratories
  • Acutaas Chemicals
  • TJI Pharma - Small Cap

FAQs on Laurus Labs Ltd. Shareprice

Laurus Labs has given better returns compared to its competitors.
Laurus Labs has grown at ~59.67% over the last 2yrs while peers have grown at a median rate of 53.58%

Laurus Labs is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Laurus Labs is 73.93, while 3 year average PE is 75.48.
Also latest EV/EBITDA of Laurus Labs is 39.96 while 3yr average is 25.3.

View FAQ's On Business

Growth Table

  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Acutaas Chemicals

Balance Sheet

  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Acutaas Chemicals

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Acutaas Chemicals

Cash Flow

  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Acutaas Chemicals

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Acutaas Chemicals

Quarterly Results

  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Acutaas Chemicals

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Laurus Labs Ltd. Financials

Balance sheet of Laurus Labs is strong.
But short term working capital might become an issue for this company.

The net debt of Laurus Labs is decreasing.
Latest net debt of Laurus Labs is ₹2,086 Crs as of Sep-25.
This is less than Mar-25 when it was ₹2,405 Crs.

Yes, profit is increasing.
The profit of Laurus Labs is ₹680 Crs for TTM, ₹358 Crs for Mar 2025 and ₹158 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Laurus Labs latest dividend payout ratio is 18.06% and 3yr average dividend payout ratio is 19.71%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech